IN-B00009

DRUG2 trials

Sponsors

HK inno.N Corporation

Conditions

Diabetes (DM)Diabetes Mellitus Type 2Obesity &Amp; Overweight

Phase 3

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

Not yet recruitingNCT07192263

HK inno.N CorporationObesity &Amp; Overweight

Start: 2025-09-22End: 2027-09-30Target: 300Updated: 2025-09-25

Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

Not yet recruitingNCT07308184

HK inno.N CorporationDiabetes (DM), Diabetes Mellitus Type 2

Start: 2025-12-31End: 2027-09-30Target: 110Updated: 2025-12-29